Skip to main content
Caplight Logo









Neurone

Neurone

Overview

Neurone is a venture capital firm founded in 2019 and based in Luxembourg . The firm invests in technology companies across geographies, stages, and sectors, from consumer technology to enterprise software and life sciences . It also operates as a startup studio, launching new companies and providing support to kickstart their businesses .

Year Founded

2019

Portfolio Companies

3

Investments

Neurone investments
CompanyDateStageLead
VirailJan 2021VC RoundCo-investor
BiocentisNov 2025GrantCo-investor
ViamMar 2025Series CCo-investor

Key People

Teodoro D'Ambrosio

Founder and Partner

Tommaso Alderigi

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Neurone based?

Headquarters information for Neurone is not publicly available.

When was Neurone founded?

Neurone was founded in 2019.

How many portfolio companies does Neurone have?

Neurone has 3 portfolio companies in Caplight's dataset.

What are some companies in Neurone's portfolio?

Portfolio companies visible on Caplight include Virail, Biocentis, Viam.

What was Neurone's most recent investment shown here?

Neurone's most recent investment in this portfolio sample was in Biocentis in 2025.

What sectors does Neurone focus on?

Neurone focuses on Healthcare & Life Sciences, Consumer & Commerce, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does Neurone focus on?

Stage focus information for Neurone is not publicly available.

What is Neurone's AUM?

Neurone's assets under management are estimated between $100.0M and $250.0M.

Firmographic Details

Headquarters—
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?